Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00053378 · ClinicalTrials.gov registry record · Phase 2
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
A Phase 2 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT00053378: Completed Phase 2 study, sponsored by Abbott.
NCT00053378 is a Phase 2 study that has completed, run by Abbott. The registered enrollment target is 45 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00053378, a Phase 2 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
Interventions
- DRUG paricalcitol injection (Zemplar)
- BEHAVIORAL Effects on calcium regulation
- BEHAVIORAL Administration of elemental Ca during hypocalcemic ICU pts.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2002-01 |
| Phase | Phase 2 |
What the finished NCT00053378 record still lists
NCT00053378 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 3 interventions - of which paricalcitol injection (Zemplar) is the first listed.
NCT00053378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00053378 about?
NCT00053378 is a clinical study titled "A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects". A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
What is the current status of trial NCT00053378?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2002-01.
What interventions are being tested in trial NCT00053378?
The interventions under investigation include: paricalcitol injection (Zemplar) (DRUG), Effects on calcium regulation (BEHAVIORAL), Administration of elemental Ca during hypocalcemic ICU pts. (BEHAVIORAL).
Who is sponsoring clinical trial NCT00053378?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00053378's enrollment target sits among peer trials
45 1296th of 2000 higher than 679 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia